19.01.2024
The RxTest Kazakhstan is the PharmXplorer prescription audit module
It is a complex for calculating various indicators of prescriptions and their convenient display to users. The audit is conducted in the context of clinical diagnoses, treatment regimens and other characteristics of the treatment process, among the doctors of 16 specialties in polyclinics and hospitals on a regular basis. The modul works in 15 cities of Kazakhstan. The calculation is based on extrapolation of sample data using cluster analysis and hierarchical models.
The subject of the RxTest study is a quantitative and qualitative analysis of the structure of drug prescriptions among doctors of various specialties in outpatient clinics and hospitals.
Operating principles
The survey of Kazakhstan doctors ensures the regular collection and the receipt of questionnaire data. Doctors personally fill out online questionnaires at website medlink.kz. The questionnaires contain issues related to general patient data: gender, age, type of visit, type of prescription, the patient’s diagnosis and treatment regimen. About 1100 doctors participate in the survey every month. An additional source of prescription records is data from medical information systems (MIS). This allows for a larger sample and more detailed information that is more relevant to the objectives of the project. The information is entered into a database and indirectly, through information processing experts, is systematized and unified into reference guides.
The process is shown in more detail in the picture below:
The advantages of the product are:
RxTest is the unique tool for evaluating drug prescriptions over time, with monthly data collection, high reliability, nosologies, treatment regimens and patient profiles for informed segmentation and targeting. With RxTest, you will be empowered to create a competitive strategy and achieve your KPIs.
Use the module:
The RxTest module is also available outside of Kazakhstan, namely in Ukraine and Uzbekistan.
If you would like to get more details about the functionality and capabilities of the RxTest module, we are pleased to provide you with additional information.
By clicking submit you consent to receive email communications about Proxima Research products and services and agree to our Terms of Use. Your data will be processed in accordance with our Privacy Police. You may opt-out at any time.
or